A Safety and Pharmacokinetic Study Between HLX02 and Herceptin®(U.S. and German Sourced) in Healthy Chinese Male Subjects
PHASE1CompletedINTERVENTIONAL
Enrollment
123
Participants
Timeline
Start Date
September 16, 2015
Primary Completion Date
May 11, 2016
Study Completion Date
January 25, 2017
Conditions
Healthy
Interventions
DRUG
HLX02
DRUG
Herceptin
Trial Locations (1)
Unknown
The Second Affiliated Hospital of Soochow University, Suzhou
All Listed Sponsors
lead
Shanghai Henlius Biotech
INDUSTRY
NCT02581748 - A Safety and Pharmacokinetic Study Between HLX02 and Herceptin®(U.S. and German Sourced) in Healthy Chinese Male Subjects | Biotech Hunter | Biotech Hunter